| oxaliplatin / Generic mfg. |
NCT00058149: Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer |
|
|
| Completed | 3 | | US, RoW | gemcitabine hydrochloride, oxaliplatin | Eastern Cooperative Oncology Group, National Cancer Institute (NCI) | Pancreatic Cancer | 07/06 | | | |
NCT00786058: A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003 |
|
|
| Approved for marketing | 3 | | Europe | OFF in experimental arm, Eloxatin, Calciumfolinat, 5-Fluorouracil | CONKO-Studiengruppe, Sanofi, medac GmbH, Amgen | Pancreatic Cancer | | | | |
NCT01121848: Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer |
|
|
| Completed | 3 | 108 | Canada | Leucovorin, OXALIPLATIN, 5-Fluorouracil | Sanofi | Pancreatic Neoplasms | 10/13 | 10/13 | | |
PANUSCO, NCT01362582: Comparing Parenteral Nutrition vs Best Supportive Nutritional Care in Patients With Pancreatic Cancer |
|
|
| Terminated | 3 | 32 | Europe | SMOF Kabiven | National Center for Tumor Diseases, Heidelberg, Heidelberg University | Pancreatic Cancer | 08/14 | 09/14 | | |
NEOPAC, NCT01521702: NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer |
|
|
| Completed | 3 | 2 | Europe | Neoadjuvant chemotherapy, surgery and Adjuvant chemotherapy | Institut Paoli-Calmettes | Pancreas Cancer | 02/15 | 02/15 | | |
